Latest Central Nervous System biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Vall d'Hebron participates in a study to update the diagnostic criteria for cerebral amyloid angiopathy

by Vall d’Hebron

2 years ago
cerebral amyloid angiopathy, beta-amyloid, superficial siderosis, Vall d’Hebron

The international study incorporates new magnetic resonance markers to increase sensitivity in the diagnosis of this disease.

Mantener la salud muscular es clave para la calidad de vida de niños y adolescentes con enfermedad pulmonar crónica

by Universidad Politécnica de Madrid

2 years ago
enfermedad pulmonar crónica, fibrosis quística (FQ)

Un estudio en el que participan investigadores de la Universidad Politécnica de Madrid detecta avances relevantes en pacientes con fibrosis quística incluidos en un programa de entrenamiento de fuer...

How to identify autism spectrum disorder

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
autism spectrum disorder

Autism is a disorder notable for developmental deficits affecting socialisation, communication, imagination and behaviour. In Europe, it affects 1 in 100 children and its causes are still unknown. It ...

UB researchers identify new model of cerebral cortex development linked to reelin protein expression

by Universitat de Barcelona

2 years ago
Reelin, pioneer CR neurons, cortical GABAergic interneurons

The correct development of the brain cortex is an essential process for the acquisition of correct cognitive skills. Reelin, a key extracellular protein in neuronal migration and synaptic plasticity, ...

Juan Pedro Bolaños, investigador del IBSAL, revisa la regulación del metabolismo celular por endocannabinoides en ‘Nature Metabolism'

by Instituto de Investigación Biomédica de Salamanca - IBSAL

2 years ago
metabolismo celular, endocannabinoides, ‘Nature Metabolism

El sistema de señalización por endocannabinoides, esto es, el conjunto formado por los receptores cannabinoides y sus ligandos naturales -tanto endógenos como los derivados de la plana Cannabis sat...

Minoryx‘s Marketing Authorization Application for its lead candidate leriglitazone validated by EMA for orphan indication X-linked Adrenoleukodystrophy (X-ALD)

by Minoryx Therapeutics

2 years ago
leriglitazone, Adrenoleukodystrophy, X-linked adrenoleukodystrophy (X-ALD)., Minoryx

Minoryx Therapeutics announces that it has filed a Marketing Authorization Application (MAA) for its lead candidate leriglitazone to the European Medicines Agency (EMA) for the treatment of adult male...

Characterisation of the post-acute stage of anti-NMDA receptor encephalitis

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
encephalitis, NMDA receptor

The study, published in the journal The Lancet Neurology, compares the cognitive and psychiatric symptoms of patients with those of schizophrenia and concludes that the vast majority improve progressi...

El Hospital del Mar es pionero en el Estado en la monitorización a distancia de pacientes con epilepsia

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Se trata de un pequeño sensor subcutáneo que registra las crisis epilépticas que sufren y que permite al equipo médico tener un control de las crisis en línea, sin necesidad que el enfermo se des...

Cómo las mutaciones en ADAR causan el síndrome de Aicardi-Goutieres

by Revista Genética Médica

2 years ago
gen ADAR, síndrome de Aicardi-Goutieres, ADAR, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, TREX1 e IFIH1, gen ZBP1

Un equipo de investigadores del Departamento de Inmunología de la Universidad de Washington ha encontrado un mecanismo que explica cómo las mutaciones en el gen ADAR pueden provocar una enfermedad a...

A trial begins with people with Parkinson's disease to improve their mobility

by IRB Lleida. Institut de Recerca Biomèdica

2 years ago
Parkinson

This is a physical exercise training programme funded by the Carlos III Health Institute and led by the Health Cures Research Group (GRECS)

Christian Griñán: 'Factors such as stress make it easier to suffer from pathological ageing'

by Fundació Bosch i Gimpera

2 years ago
Alzheimer’s or Parkinson’s, Epigenetics

Epigenetics studies these small alterations in DNA. It is a relatively new science that in recent years has also focused on the field of neuroscience to study brain-based diseases. Christian Griñán ...

The expression of two glutaminergic genes is associated with the accumulation of the TAU protein in Alzheimer’s disease

by Hospital de la Santa Creu i Sant Pau

2 years ago
TAU protein, APOE and SLC1A2 genes

Researchers’ hypothesis is that both APOE and SLC1A2 may be responsible for promoting a selective vulnerability in some brain regions and specific neuronal populations to accumulate TAU (and not oth...